Liver disease in erythropoietic protoporphyria;Enfermedad hepática en la protoporfiria eritropoyética

Gastroenterologia y Hepatologia

Volumn 28, Issue 10, 2005, Pages 632-636

  Bruguera, M ^a,b   Herrero, C ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; ERYTHROPOIETIC PROTOPORPHYRIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; PATHOGENESIS; PATIENT MONITORING; REVIEW;

EID: 30944467410     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-5705(05)71529-6     Document Type: Review

References (45)

1. Thunell S, Harper P, Brun A. Porphyrins, porphyrin metabolism and porphyrias. IV. Pathophysiology of erythyropoietic protoporphyria - diagnosis, care and monitoring of the patient. Scand J Clin Lab Invest. 2000;60:581-604.
2. Gouya L, Puy H, Lamoril J, Da Silva V, Grandchamp B, Nordmann Y, et al. Inheritance in erythropoietic protoporphyria: a common wild type ferrochelatase allelic variant with low expression accounts for clinical manifestation. Blood. 1999;93: 2105-10.
3. Gouya L, Puy H, Robreau AM, Liyoumi S, Lamoral J, Da Silva V, et al. Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias. Hum Genet. 2004;114:256-62.
4. Bloomer JR, Hill HD, Kools AM, Straka JG. Heme synthesis in protoporphyria. Curr Probl Dermatol. 1991;20:135-47.
5. Lecha M. Erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed. 2003;19:142-6.
6. Baart DLF, Bijilmer-Iest JC, Van Hattum J, Koningsberger J, Rademakers LH, Van Weelden H. Erythropoietic protoporphyria: clinical aspects with emphasis on the skin. Curr Probl Dermatol. 1991;20:123-34.
7. Doss MO, Frank M. Hepatobiliary implications and complications in protoporphyria, a 20-year study. Clin Biochem. 1989; 22:223-9.
8. Frank M, Doss MO. Severe liver disease in protoporphyria. Curr Probl Dermatol. 1991;20:160-7.
9. Deleo VA, Poh-Fitzpatrick M, Mathews-Roth M, Harber LC. Erythropoietic protoporphyria: 10 years experience. Am J Med. 1976;60:8-22.
10. Meerman L. Erythropoietic protoporphyria. An overview with emphasis on the liver. Scand J Gastroenterol. 2000;35 Suppl 232:79-85.
11. Rank JM, Carithers R, Bloomer J. Evidence for neurological dysfunction in end-stage protoporphyric liver disease. Hepatology. 1993;18:1404-9.
12. Herbert A, Corbin D, Williams A, Thompson D, Buckels J, Elias E. Erythropoietic protoporphyria: unusual skin and neurological problems after liver transplantation. Gastroenterology. 1991;100:1753-7.
13. Key NS, Rank JM, Freese D, Bloomer JR, Hammerschmidt DE. Hemolytic anemia in protoporphyria: possible precipitating role of liver failure and photic stress. Am J Hematol. 1992;39:202-7.
14. Bloomer JR, Enriquez R. Evidence that hepatic crystalline deposits in a patient with protoporphyria are composed of protoporphyrin. Gastroenterology. 1982;82:569-73.
15. Klatskin G, Bloomer JR. Birefringence of hepatic pigment deposits in erythropoietic protoporphyria. Specificity of polarization microscopy in the identification of hepatic protoporphyrin deposits. Gastroenterology. 1974;67:294-302.
16. Bloomer JR. Pathogenesis and therapy of liver disease in protoporphyria. Yale J Biol Med. 1979;52:39-48.
17. McCullough AJ, Barron D, Mullen KD, Petelli M, Park MC, Mukhtar H, et al. Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding. Gastroenterology. 1988;94:177-81.
18. Gorchein A, Foster R. Liver failure in protoporphyria: long-term treatment with oral charcoal. Hepatology. 1999;29:995-6.
19. Dobozy A, Csato M, Siklosi C, Simon N. Transfusion therapy for erythropoietic protoporphyria. Br J Dermatol. 1983;109: 571-6.
20. Meerman L, Verwer R, Slooff MJ, Van Hattum J, Beukeveld GJ, Kleibeuker JH, et al. Perioperative measures during liver transplantation for erythropoietic protoporphyria. Transplantation. 1994;57:155-8.
21. Potter C, Tolaymat N, Bobo R, Sharp H, Rank J, Bloomer JR. Hematin therapy in children with protoporphyric liver disease. J Pediatr Gastroenterol Nutr. 1996;23:402-7.
22. Pirlich M, Lochs H, Hartmut H, Schmidt J. Liver cirrhosis in erythropoietic protoporphyria: improvement of liver function with ursodeoxycholic acid. Am J Gastroenterol. 2001;96:3468-9.
23. Todd DJ. Erythropoietic protoporphyria. Br J Dermatol. 1994; 131:751-66.
24. Gross U, Frank M, Doss MO. Hepatic complications of erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed. 1998;14:52-7.
25. Gorchein A, Foster GR. Liver failure in protoporphyria: long-term treatment with oral charcoal. Hepatology. 1999;29:995-6.
26. Gorchein A, Chong SKF, Mowat AP. Oral activated charcoal in protoporphyria with liver damage. Br J Clin Pharmacol. 1989; 27:703P.
27. Pimstone NR, Gandhi SN, Mukerji SK. Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria. N Engl J Med. 1987;316:390-3.
28. Samuel D, Boboc B, Bernuau J, Bismuth H, Benhamou JP. Liver transplantation for protoporphyria. Evidence for the predominant role of the erythropoietic tissue in protoporphyrin over-production. Gastroenterology. 1988;95:816-9.
29. Polson RJ, Lim CK, Rolles K, Calne RY, Williams R. The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation. 1988;46:386-9.
30. Bloomer JR, Weimer MK, Bossenmaier IC, Snover DC, Payne WD, Ascher NL. Liver transplantation in a patient with protoporphyria. Gastroenterology. 1989;97:188-94.
31. Wagner S, Doss MO, Wittekind C, Backer U, Meessen D, Schmidt FW. Erythrohepatic protoporphyria with rapidly progressing liver cirrhosis. Dtsch Med Wochenschr. 1989;114:1837-41.
32. Mion FB, Faure JL, Berger F, McGregor B, Perrot H, Pailard P. Liver transplantation for erythropoietic protoporphyria. Report of a new case with subsequent medium-term follow-up. J Hepatol. 1992;16:203-7.
33. Sarkany RP, Cox TM. Autosomal recessive erythropoietic protoporphyria: a syndrome of severe photosensitivity and liver failure. QJM. 1995;88:541-9.
34. Frank M, Doss MO. Liver cirrhosis in protoporphyria: bile acid therapy and liver transplantation. Z Gastroenterol. 1995;33:399-403.
35. Dellon ES, Szczepiorkowski ZM, Dzik WH, Graeme-Cook F, Ades A, Bloomer JR, et al. Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation. 2002;73: 911-5.
36. Do KD, Banner BF, Katz E, Szymanski IO, Bonkovsky HL. Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria after orthotopic liver transplantation. Transplantation. 2002;73:469-72.
37. Steinmuller T, Doss MO, Steffen R, Blumhardt G, Bechstein WO, Frank M. et al. Liver transplantation in erythrohepatic protoporphyria. Dtsch Med Wochenschr. 1992;117:1097-102.
38. Lock G, Holstege A, Mueller AR, Christe W, Doss MO, Scholmerich J, et al. Liver failure in erythropoietic protoporphyria associated with choledocholithiasis and severe postransplantation polyneuropathy. Liver. 1996;16:211-7.
39. De Torres I, Demetris AJ, Randhawa PS. Recurrent hepatic allograft injury in erythropoietic protoporphyria. Transplantation. 1996;61:1412-3.
40. Reichheld JH, Katz E, Banner BF, Szymanski IO, Saltzman JR, Bonkovsky HL. The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria. Transplantation. 1999;67:922-8.
41. Meerman L, Haagsma EB, Gouw AS, Slooff MJ, Jansen PL. Long-term follow-up after liver transplantation for erythropoietic protoporphyria. Eur J Gastroenterol Hepatol. 1999;11:431-8.
42. Nguyen L, Blust M, Bailin M, Meléndez L, Raines DE. Photo-sensitivity and perioperative polyneuropathy complicating orthotopic liver transplantation in a patient with erythropoietic protoporphyria. Anesthesiology. 1999;91:1173-5.
43. Jiménez-Sáenz M, Caunedo-Alvarez A, Rojas M, Mata N, Villar JL, Piñar A, et al. Fallo hepático grave en la protoporfiria eritropoyética. Comunicación de un caso tratado con trasplante hepático. Med Clin (Barc). 1999;113:176-9.
44. Mooyaart BR, De Jong GM, Van der Veen S, Driessen LH, Beukeveld GJ, Grond J, et al. Hepatic disease in erythropoietic protoporphyria. Dermatologia. 1986;173:120-30.
45. Bloomer JR, Rank JM, Payne WD, Snover DC, Sharp HL, Zwiener RJ, et al. Follow-up after liver transplantation for protoporphyric liver disease. Liver Transpl Surg. 1996;2:269-75.